DEA Extends Surveillance on Mail-Order Drug Deals
Published Date: 9/5/2025
Notice
Summary
The DEA is asking to keep collecting info about mail order drug sales without changing the current form. This affects businesses that sell drugs by mail and helps the government keep track of these transactions. No new costs or deadlines are coming, just a smooth extension to keep things running.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Mail‑Order Drug Sellers: Reporting Continues
If you run a business that sells drugs by mail, the DEA will keep collecting the same information using the existing Report of Mail Order Transactions form. This is an extension without change, so there are no new costs or new reporting deadlines — you must continue submitting the same reports to help the government track these transactions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-15458, Civil Money Penalty for Actions in Contempt of an Immigration Judge's Proper Exercise of Authority
This notice of proposed rulemaking ("NPRM") would implement a provision of the Immigration and Nationality Act ("INA" or "the Act") that authorizes Immigration Judges, under regulations prescribed by the Attorney General, to sanction by civil money penalty any action (or inaction) in contempt of the proper exercise of their authority by certain individuals. The rule would: define the scope of the contempt authority; provide procedures for contempt findings, penalty determinations, and penalty payment; establish an appellate process; and implement oversight of the use of contempt authority. The rule would also make conforming changes to the grounds for practitioner discipline.
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-16850, United States of America, et al. v. CRH PLC, et al. Proposed Final Judgment and Competitive Impact Statement
2026-16775, Notice of Lodging of Proposed Consent Decree Under the Clean Water Act
Previous / Next Documents
Previous: 2025-17049, Agency Information Collection Activities: National Initiative for Cybersecurity Careers and Studies Cybersecurity Education and Training Catalog Collection
CISA’s NICCS is asking for approval to keep collecting info about cybersecurity education and training programs. This affects schools, trainers, and anyone involved in cybersecurity learning. They’re opening a 30-day window for public feedback, but no one commented during the first 60 days—so no big changes or costs are expected.
Next: 2025-17056, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Manufactured Food Regulatory Program Standards
The FDA is asking for approval to collect info about food safety programs from companies that make food. This helps keep our food safe and makes sure everyone follows the rules. If you’re in the food business, get ready for some paperwork soon, but no big costs are expected.